KCTD16 antibody (N-Term)
Quick Overview for KCTD16 antibody (N-Term) (ABIN632535)
Target
See all KCTD16 AntibodiesReactivity
Host
Clonality
Conjugate
Application
-
-
Binding Specificity
- N-Term
-
Specificity
- KCTD16 antibody was raised against the N terminal of KCTD16
-
Purification
- Affinity purified
-
Immunogen
- KCTD16 antibody was raised using the N terminal of KCTD16 corresponding to a region with amino acids KREAEYFQLPDLVKLLTPDEIKQSPDEFCHSDFEDASQGSDTRICPPSSL
-
-
-
-
Application Notes
-
WB: 1 µg/mL
Optimal conditions should be determined by the investigator. -
Comment
-
KCTD16 Blocking Peptide, (ABIN940007), is also available for use as a blocking control in assays to test for specificity of this KCTD16 antibody
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Lyophilized powder. Add distilled water for a 1 mg/mL concentration of KCTD16 antibody in PBS
-
Concentration
- Lot specific
-
Buffer
- PBS
-
Handling Advice
-
Avoid repeated freeze/thaw cycles.
Dilute only prior to immediate use. -
Storage
- 4 °C/-20 °C
-
Storage Comment
- Store at 2-8 °C for short periods. For longer periods of storage, store at -20 °C.
-
-
- KCTD16 (Potassium Channel Tetramerisation Domain Containing 16 (KCTD16))
-
Alternative Name
- KCTD16
-
Background
- KCTD16 is an auxiliary subunit of GABA-B receptors that determine the pharmacology and kinetics of the receptor response. It increases agonist potency and markedly alter the G-protein signaling of the receptors by accelerating onset and promoting desensitization.
-
Molecular Weight
- 49 kDa (MW of target protein)
-
Pathways
- Synaptic Membrane, Regulation of G-Protein Coupled Receptor Protein Signaling
Target
-